Drug profile · INN
levallorphan tartrate
LORFAN
levallorphan tartrate (LORFAN) is a kappa opioid receptor partial agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — levallorphan tartrate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
levallorphan tartrate (LORFAN) is a kappa opioid receptor partial agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Kappa opioid receptor partial agonist
Primary target: Kappa-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is levallorphan tartrate?
levallorphan tartrate (LORFAN) is a kappa opioid receptor partial agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for levallorphan tartrate?
LORFAN is a marketed brand name for levallorphan tartrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of levallorphan tartrate?
levallorphan tartrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.